Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Observational × Tapentadol × Clear all

Status

Sponsor Class

Study Type

Observational 1 Interventional 1

Sponsor

Conditions

Neuralgia 1 Neoplasms 1 Cancer Pain 1

Interventions

Surveys and Questionnaires 442 Blood Specimen Collection 337 Surgical Procedures, Operative 123 Radiotherapy 117 Interviews as Topic 114 Drug Therapy 104 Observation 97 Magnetic Resonance Spectroscopy 89 Biopsy 86 Specimen Handling 61 Data Collection 60 Neoadjuvant Therapy 56 Magnetic Resonance Imaging 56 Immunohistochemistry 53 Immune Checkpoint Inhibitors 49 Watchful Waiting 45 Positron Emission Tomography Computed Tomography 40 Bevacizumab 40 Liquid Biopsy 38 Ultrasonography 37 Radiosurgery 37 pembrolizumab 35 Therapeutics 35 Gene Expression Profiling 35 Immunotherapy 33 Hematologic Tests 33 Focus Groups 32 Colonoscopy 32 Hepatectomy 30 Tomography, X-Ray Computed 29

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01946555 2016-04-14

RER

Mario Negri Institute for Pharmacological Research

Cancer Pain, Neoplasms, Neuralgia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡